A new study has demonstrated successful reprogramming of myofibroblasts into hepatocytes in a mouse model of chemically induced liver fibrosis. The researchers virally induced expression of several transcription factors in fibrosis-promoting myofibroblasts to convert these cells into hepatocytes. This in vivo reprogramming resulted in reduced liver fibrosis, suggesting that this approach could present a new regenerative treatment strategy after liver damage.